<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Hyeon DY</submitter><pubmed_abstract>We report proteogenomic analysis of locally advanced cervical cancer (LACC). Exome-seq data revealed predominant alterations of keratinization-TP53 regulation and O-glycosylation-TP53 regulation axes in squamous and adeno-LACC, respectively, compared to in early-stage cervical cancer. Integrated clustering of mRNA, protein, and phosphorylation data identified six subtypes (Sub1-6) of LACC among which Sub3, 5, and 6 showed the treatment-resistant nature with poor local recurrence-free survival. Elevated immune and extracellular matrix (ECM) activation mediated by activated stroma (PDGFD and CXCL1&lt;sup>high&lt;/sup> fibroblasts) characterized the immune-hot Sub3 enriched with MUC5AC&lt;sup>high&lt;/sup> epithelial cells (ECs). Increased epithelial-mesenchymal-transition (EMT) and ECM remodeling charac</pubmed_abstract><journal>Molecular cancer</journal><pagination>77</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11908047</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.</pubmed_title><pmcid>PMC11908047</pmcid><pubmed_authors>Kim SS</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Ku JL</pubmed_authors><pubmed_authors>Hong EK</pubmed_authors><pubmed_authors>Park KS</pubmed_authors><pubmed_authors>Choi W</pubmed_authors><pubmed_authors>Yoo CW</pubmed_authors><pubmed_authors>Kim JY</pubmed_authors><pubmed_authors>Kang C</pubmed_authors><pubmed_authors>Madar IH</pubmed_authors><pubmed_authors>Baek HJ</pubmed_authors><pubmed_authors>Kang J</pubmed_authors><pubmed_authors>Shin DH</pubmed_authors><pubmed_authors>Kim SJ</pubmed_authors><pubmed_authors>Shin Y</pubmed_authors><pubmed_authors>Shin HJ</pubmed_authors><pubmed_authors>Bae J</pubmed_authors><pubmed_authors>Back S</pubmed_authors><pubmed_authors>Jeong J</pubmed_authors><pubmed_authors>Jung E</pubmed_authors><pubmed_authors>Lee SJ</pubmed_authors><pubmed_authors>Jung K</pubmed_authors><pubmed_authors>Nam D</pubmed_authors><pubmed_authors>Kim JK</pubmed_authors><pubmed_authors>Bae YK</pubmed_authors><pubmed_authors>Hyeon DY</pubmed_authors><pubmed_authors>Lim MC</pubmed_authors><pubmed_authors>Kim DK</pubmed_authors><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Hwang D</pubmed_authors><pubmed_authors>Park GW</pubmed_authors><pubmed_authors>Lee SW</pubmed_authors><pubmed_authors>Cho SY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.</name><description>We report proteogenomic analysis of locally advanced cervical cancer (LACC). Exome-seq data revealed predominant alterations of keratinization-TP53 regulation and O-glycosylation-TP53 regulation axes in squamous and adeno-LACC, respectively, compared to in early-stage cervical cancer. Integrated clustering of mRNA, protein, and phosphorylation data identified six subtypes (Sub1-6) of LACC among which Sub3, 5, and 6 showed the treatment-resistant nature with poor local recurrence-free survival. Elevated immune and extracellular matrix (ECM) activation mediated by activated stroma (PDGFD and CXCL1&lt;sup>high&lt;/sup> fibroblasts) characterized the immune-hot Sub3 enriched with MUC5AC&lt;sup>high&lt;/sup> epithelial cells (ECs). Increased epithelial-mesenchymal-transition (EMT) and ECM remodeling charac</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-02T07:17:11.478Z</modification><creation>2025-04-05T12:39:00.238Z</creation></dates><accession>S-EPMC11908047</accession><cross_references><pubmed>40087745</pubmed><doi>10.1186/s12943-025-02256-3</doi></cross_references></HashMap>